Free tool
FAERS Monitor: Etopophos Preservative Free
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020457 or its brand name (Etopophos Preservative Free, Etoposide Phosphate). Reports on generic versions are filed under their own applications.
Reports
1,635
Serious
1,491
91% of reports
Hospitalization
592
Death reported
296
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use200
- disease progression163
- product use in unapproved indication93
- acute kidney injury83
- thrombocytopenia82
- febrile neutropenia72
- pyrexia71
- drug ineffective68
- malignant neoplasm progression68
- neutropenia61
- product storage error61
- anaemia59
- pancytopenia59
- death54
- mucosal inflammation54
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 6 |
| 2005 | 4 |
| 2006 | 10 |
| 2007 | 11 |
| 2010 | 3 |
| 2012 | 19 |
| 2013 | 57 |
| 2014 | 52 |
| 2015 | 68 |
| 2016 | 126 |
| 2017 | 86 |
| 2018 | 182 |
| 2019 | 164 |
| 2020 | 95 |
| 2021 | 107 |
| 2022 | 151 |
| 2023 | 188 |
| 2024 | 138 |
| 2025 | 102 |
| 2026 | 66 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,524 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| mucosal inflammationSignal | 54 | 26.6 | 20.4 | 1,303 |
| disease progressionSignal | 163 | 17.7 | 15.3 | 2,570 |
| febrile neutropeniaSignal | 72 | 14.0 | 11.2 | 856 |
| pancytopeniaSignal | 59 | 13.6 | 10.6 | 677 |
| thrombocytopeniaSignal | 82 | 9.4 | 7.6 | 613 |
| product storage errorSignal | 61 | 9.0 | 7.0 | 425 |
| malignant neoplasm progressionSignal | 68 | 8.5 | 6.8 | 448 |
| acute kidney injurySignal | 83 | 7.0 | 5.7 | 422 |
| neutropeniaSignal | 61 | 5.8 | 4.5 | 237 |
| product use in unapproved indicationSignal | 93 | 4.8 | 4.0 | 282 |
| anaemiaSignal | 59 | 4.0 | 3.1 | 130 |
| off label useSignal | 200 | 2.9 | 2.6 | 265 |
| pyrexiaSignal | 71 | 2.6 | 2.1 | 72 |
| death | 54 | 0.8 | 0.6 | 2 |
| drug ineffective | 68 | 0.7 | 0.5 | 12 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.